We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Study of BBP-711 (ORF-229) in Healthy Adult Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04876924
Recruitment Status : Completed
First Posted : May 7, 2021
Last Update Posted : March 21, 2022
Information provided by (Responsible Party):
Cantero Therapeutics, a BridgeBio company

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 27, 2022
Actual Study Completion Date : February 27, 2022